Global Chickenpox (Varicella) Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Chickenpox (Varicella) Vaccine market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Chickenpox (Varicella) Vaccine industry chain, the market status of Kids Injection (Monovalent Vaccine, Combination Vaccine), Adults Injection (Monovalent Vaccine, Combination Vaccine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Chickenpox (Varicella) Vaccine.

Regionally, the report analyzes the Chickenpox (Varicella) Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Chickenpox (Varicella) Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Chickenpox (Varicella) Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Chickenpox (Varicella) Vaccine industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Doses), revenue generated, and market share of different by Type (e.g., Monovalent Vaccine, Combination Vaccine).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Chickenpox (Varicella) Vaccine market.

Regional Analysis: The report involves examining the Chickenpox (Varicella) Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Chickenpox (Varicella) Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Chickenpox (Varicella) Vaccine:
Company Analysis: Report covers individual Chickenpox (Varicella) Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Chickenpox (Varicella) Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Kids Injection, Adults Injection).

Technology Analysis: Report covers specific technologies relevant to Chickenpox (Varicella) Vaccine. It assesses the current state, advancements, and potential future developments in Chickenpox (Varicella) Vaccine areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Chickenpox (Varicella) Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Chickenpox (Varicella) Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
    Monovalent Vaccine
    Combination Vaccine

Market segment by Application
    Kids Injection
    Adults Injection

Major players covered
    Merck & Co.
    Sanofi Pasteur
    GSK
    Shanghai Institute
    BCHT
    Changsheng
    Keygen
    Green Cross
    Biken

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Chickenpox (Varicella) Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Chickenpox (Varicella) Vaccine, with price, sales, revenue and global market share of Chickenpox (Varicella) Vaccine from 2019 to 2024.
Chapter 3, the Chickenpox (Varicella) Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Chickenpox (Varicella) Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Chickenpox (Varicella) Vaccine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Chickenpox (Varicella) Vaccine.
Chapter 14 and 15, to describe Chickenpox (Varicella) Vaccine sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Chickenpox (Varicella) Vaccine
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Chickenpox (Varicella) Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Monovalent Vaccine
        1.3.3 Combination Vaccine
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Chickenpox (Varicella) Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Kids Injection
        1.4.3 Adults Injection
    1.5 Global Chickenpox (Varicella) Vaccine Market Size & Forecast
        1.5.1 Global Chickenpox (Varicella) Vaccine Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Chickenpox (Varicella) Vaccine Sales Quantity (2019-2030)
        1.5.3 Global Chickenpox (Varicella) Vaccine Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 Merck & Co.
        2.1.1 Merck & Co. Details
        2.1.2 Merck & Co. Major Business
        2.1.3 Merck & Co. Chickenpox (Varicella) Vaccine Product and Services
        2.1.4 Merck & Co. Chickenpox (Varicella) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Merck & Co. Recent Developments/Updates
    2.2 Sanofi Pasteur
        2.2.1 Sanofi Pasteur Details
        2.2.2 Sanofi Pasteur Major Business
        2.2.3 Sanofi Pasteur Chickenpox (Varicella) Vaccine Product and Services
        2.2.4 Sanofi Pasteur Chickenpox (Varicella) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Sanofi Pasteur Recent Developments/Updates
    2.3 GSK
        2.3.1 GSK Details
        2.3.2 GSK Major Business
        2.3.3 GSK Chickenpox (Varicella) Vaccine Product and Services
        2.3.4 GSK Chickenpox (Varicella) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 GSK Recent Developments/Updates
    2.4 Shanghai Institute
        2.4.1 Shanghai Institute Details
        2.4.2 Shanghai Institute Major Business
        2.4.3 Shanghai Institute Chickenpox (Varicella) Vaccine Product and Services
        2.4.4 Shanghai Institute Chickenpox (Varicella) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Shanghai Institute Recent Developments/Updates
    2.5 BCHT
        2.5.1 BCHT Details
        2.5.2 BCHT Major Business
        2.5.3 BCHT Chickenpox (Varicella) Vaccine Product and Services
        2.5.4 BCHT Chickenpox (Varicella) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 BCHT Recent Developments/Updates
    2.6 Changsheng
        2.6.1 Changsheng Details
        2.6.2 Changsheng Major Business
        2.6.3 Changsheng Chickenpox (Varicella) Vaccine Product and Services
        2.6.4 Changsheng Chickenpox (Varicella) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Changsheng Recent Developments/Updates
    2.7 Keygen
        2.7.1 Keygen Details
        2.7.2 Keygen Major Business
        2.7.3 Keygen Chickenpox (Varicella) Vaccine Product and Services
        2.7.4 Keygen Chickenpox (Varicella) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Keygen Recent Developments/Updates
    2.8 Green Cross
        2.8.1 Green Cross Details
        2.8.2 Green Cross Major Business
        2.8.3 Green Cross Chickenpox (Varicella) Vaccine Product and Services
        2.8.4 Green Cross Chickenpox (Varicella) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Green Cross Recent Developments/Updates
    2.9 Biken
        2.9.1 Biken Details
        2.9.2 Biken Major Business
        2.9.3 Biken Chickenpox (Varicella) Vaccine Product and Services
        2.9.4 Biken Chickenpox (Varicella) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Biken Recent Developments/Updates

3 Competitive Environment: Chickenpox (Varicella) Vaccine by Manufacturer
    3.1 Global Chickenpox (Varicella) Vaccine Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Chickenpox (Varicella) Vaccine Revenue by Manufacturer (2019-2024)
    3.3 Global Chickenpox (Varicella) Vaccine Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Chickenpox (Varicella) Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Chickenpox (Varicella) Vaccine Manufacturer Market Share in 2023
        3.4.2 Top 6 Chickenpox (Varicella) Vaccine Manufacturer Market Share in 2023
    3.5 Chickenpox (Varicella) Vaccine Market: Overall Company Footprint Analysis
        3.5.1 Chickenpox (Varicella) Vaccine Market: Region Footprint
        3.5.2 Chickenpox (Varicella) Vaccine Market: Company Product Type Footprint
        3.5.3 Chickenpox (Varicella) Vaccine Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Chickenpox (Varicella) Vaccine Market Size by Region
        4.1.1 Global Chickenpox (Varicella) Vaccine Sales Quantity by Region (2019-2030)
        4.1.2 Global Chickenpox (Varicella) Vaccine Consumption Value by Region (2019-2030)
        4.1.3 Global Chickenpox (Varicella) Vaccine Average Price by Region (2019-2030)
    4.2 North America Chickenpox (Varicella) Vaccine Consumption Value (2019-2030)
    4.3 Europe Chickenpox (Varicella) Vaccine Consumption Value (2019-2030)
    4.4 Asia-Pacific Chickenpox (Varicella) Vaccine Consumption Value (2019-2030)
    4.5 South America Chickenpox (Varicella) Vaccine Consumption Value (2019-2030)
    4.6 Middle East and Africa Chickenpox (Varicella) Vaccine Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Chickenpox (Varicella) Vaccine Sales Quantity by Type (2019-2030)
    5.2 Global Chickenpox (Varicella) Vaccine Consumption Value by Type (2019-2030)
    5.3 Global Chickenpox (Varicella) Vaccine Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Chickenpox (Varicella) Vaccine Sales Quantity by Application (2019-2030)
    6.2 Global Chickenpox (Varicella) Vaccine Consumption Value by Application (2019-2030)
    6.3 Global Chickenpox (Varicella) Vaccine Average Price by Application (2019-2030)

7 North America
    7.1 North America Chickenpox (Varicella) Vaccine Sales Quantity by Type (2019-2030)
    7.2 North America Chickenpox (Varicella) Vaccine Sales Quantity by Application (2019-2030)
    7.3 North America Chickenpox (Varicella) Vaccine Market Size by Country
        7.3.1 North America Chickenpox (Varicella) Vaccine Sales Quantity by Country (2019-2030)
        7.3.2 North America Chickenpox (Varicella) Vaccine Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Chickenpox (Varicella) Vaccine Sales Quantity by Type (2019-2030)
    8.2 Europe Chickenpox (Varicella) Vaccine Sales Quantity by Application (2019-2030)
    8.3 Europe Chickenpox (Varicella) Vaccine Market Size by Country
        8.3.1 Europe Chickenpox (Varicella) Vaccine Sales Quantity by Country (2019-2030)
        8.3.2 Europe Chickenpox (Varicella) Vaccine Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Chickenpox (Varicella) Vaccine Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Chickenpox (Varicella) Vaccine Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Chickenpox (Varicella) Vaccine Market Size by Region
        9.3.1 Asia-Pacific Chickenpox (Varicella) Vaccine Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Chickenpox (Varicella) Vaccine Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Chickenpox (Varicella) Vaccine Sales Quantity by Type (2019-2030)
    10.2 South America Chickenpox (Varicella) Vaccine Sales Quantity by Application (2019-2030)
    10.3 South America Chickenpox (Varicella) Vaccine Market Size by Country
        10.3.1 South America Chickenpox (Varicella) Vaccine Sales Quantity by Country (2019-2030)
        10.3.2 South America Chickenpox (Varicella) Vaccine Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Chickenpox (Varicella) Vaccine Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Chickenpox (Varicella) Vaccine Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Chickenpox (Varicella) Vaccine Market Size by Country
        11.3.1 Middle East & Africa Chickenpox (Varicella) Vaccine Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Chickenpox (Varicella) Vaccine Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Chickenpox (Varicella) Vaccine Market Drivers
    12.2 Chickenpox (Varicella) Vaccine Market Restraints
    12.3 Chickenpox (Varicella) Vaccine Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Chickenpox (Varicella) Vaccine and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Chickenpox (Varicella) Vaccine
    13.3 Chickenpox (Varicella) Vaccine Production Process
    13.4 Chickenpox (Varicella) Vaccine Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Chickenpox (Varicella) Vaccine Typical Distributors
    14.3 Chickenpox (Varicella) Vaccine Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Chickenpox (Varicella) Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Chickenpox (Varicella) Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Merck & Co. Basic Information, Manufacturing Base and Competitors
    Table 4. Merck & Co. Major Business
    Table 5. Merck & Co. Chickenpox (Varicella) Vaccine Product and Services
    Table 6. Merck & Co. Chickenpox (Varicella) Vaccine Sales Quantity (K Doses), Average Price (USD/dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 7. Merck & Co. Recent Developments/Updates
    Table 8. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
    Table 9. Sanofi Pasteur Major Business
    Table 10. Sanofi Pasteur Chickenpox (Varicella) Vaccine Product and Services
    Table 11. Sanofi Pasteur Chickenpox (Varicella) Vaccine Sales Quantity (K Doses), Average Price (USD/dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 12. Sanofi Pasteur Recent Developments/Updates
    Table 13. GSK Basic Information, Manufacturing Base and Competitors
    Table 14. GSK Major Business
    Table 15. GSK Chickenpox (Varicella) Vaccine Product and Services
    Table 16. GSK Chickenpox (Varicella) Vaccine Sales Quantity (K Doses), Average Price (USD/dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 17. GSK Recent Developments/Updates
    Table 18. Shanghai Institute Basic Information, Manufacturing Base and Competitors
    Table 19. Shanghai Institute Major Business
    Table 20. Shanghai Institute Chickenpox (Varicella) Vaccine Product and Services
    Table 21. Shanghai Institute Chickenpox (Varicella) Vaccine Sales Quantity (K Doses), Average Price (USD/dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 22. Shanghai Institute Recent Developments/Updates
    Table 23. BCHT Basic Information, Manufacturing Base and Competitors
    Table 24. BCHT Major Business
    Table 25. BCHT Chickenpox (Varicella) Vaccine Product and Services
    Table 26. BCHT Chickenpox (Varicella) Vaccine Sales Quantity (K Doses), Average Price (USD/dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 27. BCHT Recent Developments/Updates
    Table 28. Changsheng Basic Information, Manufacturing Base and Competitors
    Table 29. Changsheng Major Business
    Table 30. Changsheng Chickenpox (Varicella) Vaccine Product and Services
    Table 31. Changsheng Chickenpox (Varicella) Vaccine Sales Quantity (K Doses), Average Price (USD/dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 32. Changsheng Recent Developments/Updates
    Table 33. Keygen Basic Information, Manufacturing Base and Competitors
    Table 34. Keygen Major Business
    Table 35. Keygen Chickenpox (Varicella) Vaccine Product and Services
    Table 36. Keygen Chickenpox (Varicella) Vaccine Sales Quantity (K Doses), Average Price (USD/dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 37. Keygen Recent Developments/Updates
    Table 38. Green Cross Basic Information, Manufacturing Base and Competitors
    Table 39. Green Cross Major Business
    Table 40. Green Cross Chickenpox (Varicella) Vaccine Product and Services
    Table 41. Green Cross Chickenpox (Varicella) Vaccine Sales Quantity (K Doses), Average Price (USD/dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 42. Green Cross Recent Developments/Updates
    Table 43. Biken Basic Information, Manufacturing Base and Competitors
    Table 44. Biken Major Business
    Table 45. Biken Chickenpox (Varicella) Vaccine Product and Services
    Table 46. Biken Chickenpox (Varicella) Vaccine Sales Quantity (K Doses), Average Price (USD/dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 47. Biken Recent Developments/Updates
    Table 48. Global Chickenpox (Varicella) Vaccine Sales Quantity by Manufacturer (2019-2024) & (K Doses)
    Table 49. Global Chickenpox (Varicella) Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
    Table 50. Global Chickenpox (Varicella) Vaccine Average Price by Manufacturer (2019-2024) & (USD/dose)
    Table 51. Market Position of Manufacturers in Chickenpox (Varicella) Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
    Table 52. Head Office and Chickenpox (Varicella) Vaccine Production Site of Key Manufacturer
    Table 53. Chickenpox (Varicella) Vaccine Market: Company Product Type Footprint
    Table 54. Chickenpox (Varicella) Vaccine Market: Company Product Application Footprint
    Table 55. Chickenpox (Varicella) Vaccine New Market Entrants and Barriers to Market Entry
    Table 56. Chickenpox (Varicella) Vaccine Mergers, Acquisition, Agreements, and Collaborations
    Table 57. Global Chickenpox (Varicella) Vaccine Sales Quantity by Region (2019-2024) & (K Doses)
    Table 58. Global Chickenpox (Varicella) Vaccine Sales Quantity by Region (2025-2030) & (K Doses)
    Table 59. Global Chickenpox (Varicella) Vaccine Consumption Value by Region (2019-2024) & (USD Million)
    Table 60. Global Chickenpox (Varicella) Vaccine Consumption Value by Region (2025-2030) & (USD Million)
    Table 61. Global Chickenpox (Varicella) Vaccine Average Price by Region (2019-2024) & (USD/dose)
    Table 62. Global Chickenpox (Varicella) Vaccine Average Price by Region (2025-2030) & (USD/dose)
    Table 63. Global Chickenpox (Varicella) Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
    Table 64. Global Chickenpox (Varicella) Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
    Table 65. Global Chickenpox (Varicella) Vaccine Consumption Value by Type (2019-2024) & (USD Million)
    Table 66. Global Chickenpox (Varicella) Vaccine Consumption Value by Type (2025-2030) & (USD Million)
    Table 67. Global Chickenpox (Varicella) Vaccine Average Price by Type (2019-2024) & (USD/dose)
    Table 68. Global Chickenpox (Varicella) Vaccine Average Price by Type (2025-2030) & (USD/dose)
    Table 69. Global Chickenpox (Varicella) Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
    Table 70. Global Chickenpox (Varicella) Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
    Table 71. Global Chickenpox (Varicella) Vaccine Consumption Value by Application (2019-2024) & (USD Million)
    Table 72. Global Chickenpox (Varicella) Vaccine Consumption Value by Application (2025-2030) & (USD Million)
    Table 73. Global Chickenpox (Varicella) Vaccine Average Price by Application (2019-2024) & (USD/dose)
    Table 74. Global Chickenpox (Varicella) Vaccine Average Price by Application (2025-2030) & (USD/dose)
    Table 75. North America Chickenpox (Varicella) Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
    Table 76. North America Chickenpox (Varicella) Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
    Table 77. North America Chickenpox (Varicella) Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
    Table 78. North America Chickenpox (Varicella) Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
    Table 79. North America Chickenpox (Varicella) Vaccine Sales Quantity by Country (2019-2024) & (K Doses)
    Table 80. North America Chickenpox (Varicella) Vaccine Sales Quantity by Country (2025-2030) & (K Doses)
    Table 81. North America Chickenpox (Varicella) Vaccine Consumption Value by Country (2019-2024) & (USD Million)
    Table 82. North America Chickenpox (Varicella) Vaccine Consumption Value by Country (2025-2030) & (USD Million)
    Table 83. Europe Chickenpox (Varicella) Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
    Table 84. Europe Chickenpox (Varicella) Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
    Table 85. Europe Chickenpox (Varicella) Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
    Table 86. Europe Chickenpox (Varicella) Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
    Table 87. Europe Chickenpox (Varicella) Vaccine Sales Quantity by Country (2019-2024) & (K Doses)
    Table 88. Europe Chickenpox (Varicella) Vaccine Sales Quantity by Country (2025-2030) & (K Doses)
    Table 89. Europe Chickenpox (Varicella) Vaccine Consumption Value by Country (2019-2024) & (USD Million)
    Table 90. Europe Chickenpox (Varicella) Vaccine Consumption Value by Country (2025-2030) & (USD Million)
    Table 91. Asia-Pacific Chickenpox (Varicella) Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
    Table 92. Asia-Pacific Chickenpox (Varicella) Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
    Table 93. Asia-Pacific Chickenpox (Varicella) Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
    Table 94. Asia-Pacific Chickenpox (Varicella) Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
    Table 95. Asia-Pacific Chickenpox (Varicella) Vaccine Sales Quantity by Region (2019-2024) & (K Doses)
    Table 96. Asia-Pacific Chickenpox (Varicella) Vaccine Sales Quantity by Region (2025-2030) & (K Doses)
    Table 97. Asia-Pacific Chickenpox (Varicella) Vaccine Consumption Value by Region (2019-2024) & (USD Million)
    Table 98. Asia-Pacific Chickenpox (Varicella) Vaccine Consumption Value by Region (2025-2030) & (USD Million)
    Table 99. South America Chickenpox (Varicella) Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
    Table 100. South America Chickenpox (Varicella) Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
    Table 101. South America Chickenpox (Varicella) Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
    Table 102. South America Chickenpox (Varicella) Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
    Table 103. South America Chickenpox (Varicella) Vaccine Sales Quantity by Country (2019-2024) & (K Doses)
    Table 104. South America Chickenpox (Varicella) Vaccine Sales Quantity by Country (2025-2030) & (K Doses)
    Table 105. South America Chickenpox (Varicella) Vaccine Consumption Value by Country (2019-2024) & (USD Million)
    Table 106. South America Chickenpox (Varicella) Vaccine Consumption Value by Country (2025-2030) & (USD Million)
    Table 107. Middle East & Africa Chickenpox (Varicella) Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
    Table 108. Middle East & Africa Chickenpox (Varicella) Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
    Table 109. Middle East & Africa Chickenpox (Varicella) Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
    Table 110. Middle East & Africa Chickenpox (Varicella) Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
    Table 111. Middle East & Africa Chickenpox (Varicella) Vaccine Sales Quantity by Region (2019-2024) & (K Doses)
    Table 112. Middle East & Africa Chickenpox (Varicella) Vaccine Sales Quantity by Region (2025-2030) & (K Doses)
    Table 113. Middle East & Africa Chickenpox (Varicella) Vaccine Consumption Value by Region (2019-2024) & (USD Million)
    Table 114. Middle East & Africa Chickenpox (Varicella) Vaccine Consumption Value by Region (2025-2030) & (USD Million)
    Table 115. Chickenpox (Varicella) Vaccine Raw Material
    Table 116. Key Manufacturers of Chickenpox (Varicella) Vaccine Raw Materials
    Table 117. Chickenpox (Varicella) Vaccine Typical Distributors
    Table 118. Chickenpox (Varicella) Vaccine Typical Customers
List of Figures
    Figure 1. Chickenpox (Varicella) Vaccine Picture
    Figure 2. Global Chickenpox (Varicella) Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Chickenpox (Varicella) Vaccine Consumption Value Market Share by Type in 2023
    Figure 4. Monovalent Vaccine Examples
    Figure 5. Combination Vaccine Examples
    Figure 6. Global Chickenpox (Varicella) Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 7. Global Chickenpox (Varicella) Vaccine Consumption Value Market Share by Application in 2023
    Figure 8. Kids Injection Examples
    Figure 9. Adults Injection Examples
    Figure 10. Global Chickenpox (Varicella) Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 11. Global Chickenpox (Varicella) Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 12. Global Chickenpox (Varicella) Vaccine Sales Quantity (2019-2030) & (K Doses)
    Figure 13. Global Chickenpox (Varicella) Vaccine Average Price (2019-2030) & (USD/dose)
    Figure 14. Global Chickenpox (Varicella) Vaccine Sales Quantity Market Share by Manufacturer in 2023
    Figure 15. Global Chickenpox (Varicella) Vaccine Consumption Value Market Share by Manufacturer in 2023
    Figure 16. Producer Shipments of Chickenpox (Varicella) Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
    Figure 17. Top 3 Chickenpox (Varicella) Vaccine Manufacturer (Consumption Value) Market Share in 2023
    Figure 18. Top 6 Chickenpox (Varicella) Vaccine Manufacturer (Consumption Value) Market Share in 2023
    Figure 19. Global Chickenpox (Varicella) Vaccine Sales Quantity Market Share by Region (2019-2030)
    Figure 20. Global Chickenpox (Varicella) Vaccine Consumption Value Market Share by Region (2019-2030)
    Figure 21. North America Chickenpox (Varicella) Vaccine Consumption Value (2019-2030) & (USD Million)
    Figure 22. Europe Chickenpox (Varicella) Vaccine Consumption Value (2019-2030) & (USD Million)
    Figure 23. Asia-Pacific Chickenpox (Varicella) Vaccine Consumption Value (2019-2030) & (USD Million)
    Figure 24. South America Chickenpox (Varicella) Vaccine Consumption Value (2019-2030) & (USD Million)
    Figure 25. Middle East & Africa Chickenpox (Varicella) Vaccine Consumption Value (2019-2030) & (USD Million)
    Figure 26. Global Chickenpox (Varicella) Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 27. Global Chickenpox (Varicella) Vaccine Consumption Value Market Share by Type (2019-2030)
    Figure 28. Global Chickenpox (Varicella) Vaccine Average Price by Type (2019-2030) & (USD/dose)
    Figure 29. Global Chickenpox (Varicella) Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 30. Global Chickenpox (Varicella) Vaccine Consumption Value Market Share by Application (2019-2030)
    Figure 31. Global Chickenpox (Varicella) Vaccine Average Price by Application (2019-2030) & (USD/dose)
    Figure 32. North America Chickenpox (Varicella) Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 33. North America Chickenpox (Varicella) Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 34. North America Chickenpox (Varicella) Vaccine Sales Quantity Market Share by Country (2019-2030)
    Figure 35. North America Chickenpox (Varicella) Vaccine Consumption Value Market Share by Country (2019-2030)
    Figure 36. United States Chickenpox (Varicella) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 37. Canada Chickenpox (Varicella) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 38. Mexico Chickenpox (Varicella) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 39. Europe Chickenpox (Varicella) Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 40. Europe Chickenpox (Varicella) Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 41. Europe Chickenpox (Varicella) Vaccine Sales Quantity Market Share by Country (2019-2030)
    Figure 42. Europe Chickenpox (Varicella) Vaccine Consumption Value Market Share by Country (2019-2030)
    Figure 43. Germany Chickenpox (Varicella) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 44. France Chickenpox (Varicella) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 45. United Kingdom Chickenpox (Varicella) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 46. Russia Chickenpox (Varicella) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 47. Italy Chickenpox (Varicella) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 48. Asia-Pacific Chickenpox (Varicella) Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 49. Asia-Pacific Chickenpox (Varicella) Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 50. Asia-Pacific Chickenpox (Varicella) Vaccine Sales Quantity Market Share by Region (2019-2030)
    Figure 51. Asia-Pacific Chickenpox (Varicella) Vaccine Consumption Value Market Share by Region (2019-2030)
    Figure 52. China Chickenpox (Varicella) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 53. Japan Chickenpox (Varicella) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 54. Korea Chickenpox (Varicella) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 55. India Chickenpox (Varicella) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 56. Southeast Asia Chickenpox (Varicella) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 57. Australia Chickenpox (Varicella) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 58. South America Chickenpox (Varicella) Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 59. South America Chickenpox (Varicella) Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 60. South America Chickenpox (Varicella) Vaccine Sales Quantity Market Share by Country (2019-2030)
    Figure 61. South America Chickenpox (Varicella) Vaccine Consumption Value Market Share by Country (2019-2030)
    Figure 62. Brazil Chickenpox (Varicella) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 63. Argentina Chickenpox (Varicella) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 64. Middle East & Africa Chickenpox (Varicella) Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 65. Middle East & Africa Chickenpox (Varicella) Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 66. Middle East & Africa Chickenpox (Varicella) Vaccine Sales Quantity Market Share by Region (2019-2030)
    Figure 67. Middle East & Africa Chickenpox (Varicella) Vaccine Consumption Value Market Share by Region (2019-2030)
    Figure 68. Turkey Chickenpox (Varicella) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 69. Egypt Chickenpox (Varicella) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 70. Saudi Arabia Chickenpox (Varicella) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 71. South Africa Chickenpox (Varicella) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 72. Chickenpox (Varicella) Vaccine Market Drivers
    Figure 73. Chickenpox (Varicella) Vaccine Market Restraints
    Figure 74. Chickenpox (Varicella) Vaccine Market Trends
    Figure 75. Porters Five Forces Analysis
    Figure 76. Manufacturing Cost Structure Analysis of Chickenpox (Varicella) Vaccine in 2023
    Figure 77. Manufacturing Process Analysis of Chickenpox (Varicella) Vaccine
    Figure 78. Chickenpox (Varicella) Vaccine Industrial Chain
    Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 80. Direct Channel Pros & Cons
    Figure 81. Indirect Channel Pros & Cons
    Figure 82. Methodology
    Figure 83. Research Process and Data Source

Companies Mentioned

Merck & Co.
Sanofi Pasteur
GSK
Shanghai Institute
BCHT
Changsheng
Keygen
Green Cross
Biken